Article Text

Download PDFPDF
Acute cardiovascular care
Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes

Statistics from


  • Contributors PAG and UST are involved in both designing and writing this manuscript.

  • Competing interests PAG reports serving as a consultant fees/receiving honoraria from Daiichi Sankyo, Bayer, AstraZeneca, Merck, Boehringer, New Haven Pharmaceuticals, Janssen and CSL; receiving grants from the National Institutes of Health, Daiichi Sankyo/Lilly, New Haven Pharmaceuticals, Harvard Clinical Research Institute, Bayer, Haemonetics, Duke Clinical Research Institute, Sinnowa and Coramed.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.